AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank83
3Y CAGR+29.5%
5Y CAGR+296.3%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+29.5%/yr
Annual compound
5Y CAGR
+296.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
978x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.93M-46.3%
2024$5.47M-
2023$0.00-100.0%
2022$1.35M+1858.0%
2021$69000.00+2200.0%
2020$3000.00-
2019$0.00-